Oppimi Group Achievements

October 8 2019

Outputs of AIRIPA Congress

Oppimi Group attended AIRIPA congress (Italian Association for Research and Intervention in Learning Psychopathology) last 26th September. Our 2 collaboration partners, Vimercate Hospital and University of Parma, shared compelling opinions on the use of Oppimi Console for the diagnosis and the therapy of dysgraphia through the release of 2 publications.

Here are some extract of these documents.

In this first experimental phase, Oppimi tablet tool has proven to be sensitive to the normal learning process, showing an improvement in the copying test in italics during the second experimental phase.

University of Parma

From the diagnostic point of view, Oppimi’s tool was sensitive in the discrimination of children with graphomotor difficulties, proving to be a contribution to the diagnostic process.

Vimercate Hospital

January 16 2019

Capital increase to support second phase of clinical piloting

Oppimi Group, digital innovator in the field of Clinically validated tools for diagnosing and treating learning disabilities, announces a capital increase through private placement with Wygu Investment Holdings Co. Limited.

Oppimi Group announces a capital increase in the form of a private placement. This capital increase by Wygu Investment Holdings Co. Limited comes 12 months after the entry of Pu Ying Olicom Technology Hong Kong Limited as a private investor, and aims to finance the second phase of clinical piloting of his digital ecosystem.

About Oppimi

Oppimi believes that supporting schools with innovative screening tools for early identification of learning disabilities can set struggling students on a path of success. Oppimi helps doctors by providing a high performance evaluating scale, clinically validated, that increases the diagnostic accuracy and drastically reduces the time dedicated to calculations and reports.

Oppimi supports test and treatment for children affected by learning disabilities with innovative diagnosis and therapy digital products through AI and Gamification. We are using AI for creating clinically-validated Digital Health Products for diagnosing and treating children that are affected by learning disabilities.

Ai is changing drastically how health is approching LDs, and we are enbracing big data as core. Oppimi’s algorithms, based on machine learning techniques, are able to monitor patient’s advancements and suggest new tasks for optimizing the training results. We are providing a full ecosystem that connects learning disabilities specialists, teachers and children’s parents.

Children have access from their home, while parents can consult therapy advancement and doctors, high-quality analytics. We strive to test our products at multiple levels including with a strong methodology and structured specialists validations. Then the game itself is build in respect of fair game rules without violence and in respect of clean game mechanics.

June 1 2017

Seed Investment

Getting the wheel rolling is a priority for Oppimi, now that core team is set up. We found in Pu-Ying Olicom the right investor, to make real things happen. We were looking for active investors that can help us extend our network, especially on China market. Great fit with Pu-Ying Olicom, who are very active in leveraging our entry into Asian market and accelerating research and development.

May 28 2017

Rotaract Partner

Start supporting children

Oppimi signed 2 years contract with Rotaract: Rotary Romania for the largest pilot phase of Oppimi’s Dysgraphia Platform. Thanks to Rotaract Volunteers, we will present our platform to Romanian schools and with them, on coming September 2017, we will start the first Oppimi Pilot in Europe.

December 20 2016

Core Team

Based on 2 years collaboration with worldwide partners coming from a wide range expertises, the core team is complete. Mr Ervin Ukaj, long time expert in management and tech expert in the field of handwriting recognition for the bank industry, as well as Mr Guillaume “Will” Clavel, are gathering experts all around the world. Mr Franck Da Costa hops in to structure the company and to bring aboard strong expertise in operation and game development. Dr Javad Sadri, Professor at McGill and Concordia universities, specialist in handwriting widens the research and development. Mr Marco Bonin, back-end developer and manager lays down the bases of big data. Core team is set up, digging into how to help and support children affected by learning disabilities like dysgraphia.